Steffen Goletz

University of Lübeck — Germany

Medicine · Health Sciences

28h-index2.3kcitations106works6.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Monoclonal and Polyclonal Antibodies Research(51), Glycosylation and Glycoproteins Research(49), Immunotherapy and Immune Responses(12), HER2/EGFR in Cancer Research(11), Protein purification and stability(10)

Publications106 total

Antibody-based signal amplification for single-cell proteomics by mass spectrometry
2025Open Access
047 Improved diagnostics in pemphigoid diseases: laminin β4 as a key autoantigen in previously unresolved cases with dermal binding by indirect immunofluorescence on salt-split human skin
Journal of Investigative Dermatology·2025Open Access
Meta-inflammation and endotoxemia in a highly translational porcine model of diet-induced obesity
Lab Animal·2025Open Access
Peptide ligands for the universal purification of exosomes by affinity chromatography
UNC Libraries·2025Open Access
Multi-omics analysis of keratinocytes reveals dermokine-dependent regulation of cell-cell adhesion via p120
2025Open Access
Implications of glycosylation for the development of selected cytokines and their derivatives for medical use
Biotechnology Advances·2024· 8 citedOpen Access
Meta-Inflammation and Endotoxemia in a Highly Translational Porcine Model of Diet-Induced Obesity
2024Open Access
Peptide Ligands for the Universal Purification of Exosomes by Affinity Chromatography
2024· 1 citedOpen Access
Peptide ligands for the universal purification of exosomes by affinity chromatography
Biotechnology and Bioengineering·2024· 11 citedOpen Access
Cell-based glycoengineering of extracellular vesicles through precise genome editing
New Biotechnology·2024· 7 citedOpen Access
Novel genetically glycoengineered human dendritic cell model reveals regulatory roles of α2,6-linked sialic acids in DC activation of CD4+ T cells and response to TNFα
Glycobiology·2024· 4 cited
IgG-VHH bispecific fusion antibodies: challenges and opportunities as therapeutic agents
Expert Opinion on Biological Therapy·2024· 6 citedOpen Access
Deep mining of antibody phage-display selections using Oxford Nanopore Technologies and Dual Unique Molecular Identifiers
New Biotechnology·2024· 6 citedOpen Access
Design and engineering of bispecific antibodies: insights and practical considerations
Frontiers in Bioengineering and Biotechnology·2024· 46 citedOpen Access
Chemical synthesis and immunological evaluation of cancer vaccines based on ganglioside antigens and α-galactosylceramide
RSC Medicinal Chemistry·2024· 2 citedOpen Access
Structural trends in antibody-antigen binding interfaces: a computational analysis of 1833 experimentally determined 3D structures
Computational and Structural Biotechnology Journal·2023· 30 citedOpen Access
A window into the human immune system: comprehensive characterization of the complexity of antibody complementary-determining regions in functional antibodies
mAbs·2023· 26 citedOpen Access
Clinical <i>Staphylococcus aureus</i> inhibits human T-cell activity through interaction with the PD-1 receptor
mBio·2023· 11 citedOpen Access
Exploration of cell state heterogeneity using single-cell proteomics through sensitivity-tailored data-independent acquisition
Nature Communications·2023· 92 citedOpen Access
Supplementary Table 1 and 2 from Cetuximab Resistance in Head and Neck Cancer Is Mediated by EGFR-K&lt;sub&gt;521&lt;/sub&gt; Polymorphism
2023Open Access
page 1 of 6Next →

Frequent Co-authors

Uwe Karsten(27), Antje Danielczyk(9), Peter Kristensen(8), Philippe Ulsemer(6), Kawe Toutounian(5), J. Schmidt(5), Andreas V. Madsen(5), Lasse Ebdrup Pedersen(5), Peter Astrup Christensen(4), Renate Stahn(4), Yi Cao(4), Udo Jeschke(4), Bruno Dietrich(4), Walter Fiedler(3), Jens Weidmann(3), Marc Salzberg(3), Hans Baumeister(3), G Butschak(3), Peter Ravn(3), Martin Larsen(3)